These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12750309)

  • 21. Bone marrow transplantation into hemochromatotic mice decreases hepatic and duodenal iron overload.
    Morán-Jiménez MJ; García-Bravo M; Méndez M; Gutiérrez-Vera I; Grau M; Navarro-Ordoñez S; Fontanellas A; Enríquez-de-Salamanca R
    Int J Biochem Cell Biol; 2008; 40(1):135-46. PubMed ID: 17719830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory networks for the control of body iron homeostasis and their dysregulation in HFE mediated hemochromatosis.
    Ludwiczek S; Theurl I; Bahram S; Schümann K; Weiss G
    J Cell Physiol; 2005 Aug; 204(2):489-99. PubMed ID: 15744772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iron overload in a murine model of hereditary hemochromatosis is associated with accelerated progression of osteoarthritis under mechanical stress.
    Camacho A; Simão M; Ea HK; Cohen-Solal M; Richette P; Branco J; Cancela ML
    Osteoarthritis Cartilage; 2016 Mar; 24(3):494-502. PubMed ID: 26403062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis of hereditary hemochromatosis: genetics and beyond.
    Britton RS; Fleming RE; Parkkila S; Waheed A; Sly WS; Bacon BR
    Semin Gastrointest Dis; 2002 Apr; 13(2):68-79. PubMed ID: 12064862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iron-mediated inhibition of mitochondrial manganese uptake mediates mitochondrial dysfunction in a mouse model of hemochromatosis.
    Jouihan HA; Cobine PA; Cooksey RC; Hoagland EA; Boudina S; Abel ED; Winge DR; McClain DA
    Mol Med; 2008; 14(3-4):98-108. PubMed ID: 18317567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic disruption of NRF2 promotes the development of necroinflammation and liver fibrosis in a mouse model of HFE-hereditary hemochromatosis.
    Duarte TL; Caldas C; Santos AG; Silva-Gomes S; Santos-Gonçalves A; Martins MJ; Porto G; Lopes JM
    Redox Biol; 2017 Apr; 11():157-169. PubMed ID: 27936457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.
    Bridle KR; Frazer DM; Wilkins SJ; Dixon JL; Purdie DM; Crawford DH; Subramaniam VN; Powell LW; Anderson GJ; Ramm GA
    Lancet; 2003 Feb; 361(9358):669-73. PubMed ID: 12606179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of porphyria cutanea tarda with hereditary hemochromatosis.
    Mehrany K; Drage LA; Brandhagen DJ; Pittelkow MR
    J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absorption of manganese and iron in a mouse model of hemochromatosis.
    Kim J; Buckett PD; Wessling-Resnick M
    PLoS One; 2013; 8(5):e64944. PubMed ID: 23705020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in the pathophysiology, diagnosis and treatment of hereditary hemochromatosis and other iron overload syndromes.
    Pirisi M; Avellini C; Scott CA; Toniutto P; Intersimone D; Aprile G; Branca B; Fumo E
    Adv Clin Path; 2001 Oct; 5(4):121-31. PubMed ID: 17582936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term sequelae of HFE deletion in C57BL/6 x 129/O1a mice, an animal model for hereditary haemochromatosis.
    Lebeau A; Frank J; Biesalski HK; Weiss G; Srai SK; Simpson RJ; McKie AT; Bahram S; Gilfillan S; Schümann K
    Eur J Clin Invest; 2002 Aug; 32(8):603-12. PubMed ID: 12190960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage migration inhibitory factor provides cardioprotection during ischemia/reperfusion by reducing oxidative stress.
    Koga K; Kenessey A; Powell SR; Sison CP; Miller EJ; Ojamaa K
    Antioxid Redox Signal; 2011 Apr; 14(7):1191-202. PubMed ID: 20831446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of HFE in iron metabolism, hereditary haemochromatosis, anaemia of chronic disease, and secondary iron overload.
    Townsend A; Drakesmith H
    Lancet; 2002 Mar; 359(9308):786-90. PubMed ID: 11888608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of genes related to HFE and iron status in mouse duodenal epithelium.
    Abgueguen E; Toutain B; Bédrine H; Chicault C; Orhant M; Aubry M; Monnier A; Mottier S; Jouan H; Bahram S; Mosser J; Fergelot P
    Mamm Genome; 2006 May; 17(5):430-50. PubMed ID: 16688533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iron-overload-related disease in HFE hereditary hemochromatosis.
    Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
    N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of hemochromatosis mutations on iron overload of thalassemia major.
    Longo F; Zecchina G; Sbaiz L; Fischer R; Piga A; Camaschella C
    Haematologica; 1999 Sep; 84(9):799-803. PubMed ID: 10477452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal regulation of HFE mRNA expression does not contribute to primary iron overload.
    Vercesi E; Cerani P; Rolandi V; Rovati A; Bergamaschi G
    Haematologica; 2000 Aug; 85(8):787-91. PubMed ID: 10942923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased Bone Formation Explains Osteoporosis in a Genetic Mouse Model of Hemochromatosiss.
    Doyard M; Chappard D; Leroyer P; Roth MP; Loréal O; Guggenbuhl P
    PLoS One; 2016; 11(2):e0148292. PubMed ID: 26829642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiology of iron transport and the hemochromatosis gene.
    Pietrangelo A
    Am J Physiol Gastrointest Liver Physiol; 2002 Mar; 282(3):G403-14. PubMed ID: 11841990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemochromatosis protein (HFE) and tumor necrosis factor receptor 2 (TNFR2) influence tissue iron levels: elements of a common gut pathway?
    Meyer PN; Gerhard GS; Yoshida Y; Yoshida M; Chorney KA; Beard J; Kauffman EJ; Weiss G; Chorney MJ
    Blood Cells Mol Dis; 2002; 29(3):274-85. PubMed ID: 12547217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.